Search Within

Gastrointestinal Oncology Service

  1. "Massachusetts Medical Society"
Formats
  1. Journal Article (28)
  2. Editorial (4)
  3. Research Letter (4)
  4. Correspondence (2)
  5. Review (1)
Groups
  1. Department of Medicine (39)
  2. Solid Tumor Oncology Division (39)
  3. Center for Pancreatic Cancer Research (15)
  4. Surgery (7)
  5. Survivorship Research (6)
  6. Hematology-Oncology Fellows (5)

More Groups

People
  1. Luis Diaz (7)
  2. Rona Yaeger (7)
  3. Andrea Cercek Hanjis (6)
  4. Leonard Saltz (6)
  5. Benoit Rousseau (4)
  6. Eileen O'Reilly (4)

More People

Years
  1. 2025 (7)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. New England Journal of Medicine (39)
Publishers
  1. Massachusetts Medical Society (39)

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab deruxtecan or ramucirumab plus paclitaxel in gastric cancer
    Journal Article

    Shitara, K.; van Cutsem, E.; Gümüş, M.; Lonardi, S.; de la Fouchardière, C.; Coutzac, C.; Dekervel, J.; Hochhauser, D.; Shen, L.; Mansoor, W.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Perioperative durvalumab in gastric and gastroesophageal junction cancer
    Journal Article

    Janjigian, Y. Y.; Al-Batran, S. E.; Wainberg, Z. A.; Muro, K.; Molena, D.; Van Cutsem, E.; Hyung, W. J.; Wyrwicz, L.; Oh, D. Y.; Omori, T.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Encorafenib, cetuximab, and mFOLFOX6 in BRAF-mutated colorectal cancer
    Journal Article

    Elez, E.; Yoshino, T.; Shen, L.; Lonardi, S.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • The duration of immunotherapy for mismatch repair-deficient cancers
    Research Letter

    Rousseau, B.; White, J. R.; Cercek, A.; Diaz, L. A. Jr
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Efficacy of zenocutuzumab in NRG1 fusion-positive cancer
    Journal Article

    Schram, A. M.; Goto, K.; Kim, D. W.; Macarulla, T.; Hollebecque, A.; O'Reilly, E. M.; Ou, S. H. I.; Rodon, J.; Rha, S. Y.; Nishino, K.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Multimodal treatment in locally advanced esophageal adenocarcinoma - Two interventions better than three?
    Editorial

    Kelsen, D. P.
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Zolbetuximab in gastric or gastroesophageal junction adenocarcinoma
    Research Letter

    Shitara, K.; Shah, M. A.; Lordick, F.; Van Cutsem, E.; Ilson, D. H.; Klempner, S. J.; Kang, Y. K.; Lonardi, S.; Hung, Y. P.; Yamaguchi, K.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Pembrolizumab in HER2-positive gastric cancer
    Research Letter

    Janjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J. P.; Yañez, P.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Neoadjuvant treatment of mismatch repair–deficient colon cancer — Clinically meaningful?
    Editorial

    Cercek, A.
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save